全文获取类型
收费全文 | 155600篇 |
免费 | 13731篇 |
国内免费 | 5982篇 |
专业分类
耳鼻咽喉 | 686篇 |
儿科学 | 4728篇 |
妇产科学 | 2519篇 |
基础医学 | 20864篇 |
口腔科学 | 2820篇 |
临床医学 | 16936篇 |
内科学 | 26549篇 |
皮肤病学 | 1623篇 |
神经病学 | 12121篇 |
特种医学 | 4069篇 |
外国民族医学 | 29篇 |
外科学 | 10844篇 |
综合类 | 23419篇 |
现状与发展 | 35篇 |
一般理论 | 4篇 |
预防医学 | 11828篇 |
眼科学 | 2186篇 |
药学 | 19248篇 |
66篇 | |
中国医学 | 5907篇 |
肿瘤学 | 8832篇 |
出版年
2024年 | 305篇 |
2023年 | 2254篇 |
2022年 | 3175篇 |
2021年 | 6407篇 |
2020年 | 5601篇 |
2019年 | 5223篇 |
2018年 | 5047篇 |
2017年 | 5485篇 |
2016年 | 5741篇 |
2015年 | 6168篇 |
2014年 | 9817篇 |
2013年 | 11680篇 |
2012年 | 9541篇 |
2011年 | 10325篇 |
2010年 | 8330篇 |
2009年 | 7903篇 |
2008年 | 8036篇 |
2007年 | 7814篇 |
2006年 | 7047篇 |
2005年 | 6521篇 |
2004年 | 5394篇 |
2003年 | 4784篇 |
2002年 | 3838篇 |
2001年 | 3343篇 |
2000年 | 2836篇 |
1999年 | 2499篇 |
1998年 | 2252篇 |
1997年 | 2026篇 |
1996年 | 1743篇 |
1995年 | 1477篇 |
1994年 | 1456篇 |
1993年 | 1137篇 |
1992年 | 1026篇 |
1991年 | 1014篇 |
1990年 | 861篇 |
1989年 | 711篇 |
1988年 | 672篇 |
1987年 | 610篇 |
1986年 | 551篇 |
1985年 | 820篇 |
1984年 | 718篇 |
1983年 | 532篇 |
1982年 | 533篇 |
1981年 | 472篇 |
1980年 | 399篇 |
1979年 | 268篇 |
1978年 | 207篇 |
1977年 | 172篇 |
1976年 | 168篇 |
1975年 | 106篇 |
排序方式: 共有10000条查询结果,搜索用时 296 毫秒
41.
42.
《Paediatrics & Child Health》2020,30(4):139-143
Premature infants are physiologically immature and are particularly vulnerable to systemic illnesses. Instability of vital signs related to immaturity of organ systems are common but may also represent early manifestations of serious illness. While vital signs are frequently or continuously monitored in critically unwell neonates, changes in these parameters are subtle in the early phase of illness such as sepsis and difficult to interpret using traditional neonatal monitoring tools. Recent advances in identifying trends and patterns of vital signs in the pre-clinical phase of the illness, particularly in the field of heart rate characteristics monitoring has opened up the potential to improve outcomes through rapid and timely investigations and early intervention. This article reviews the current evidence in predictive monitoring of neonates and discusses potential clinical implications. 相似文献
43.
44.
Monika Scheer Christian Vokuhl Iris Veit‐Friedrich Marc Münter Thekla von Kalle Michael Greulich Steffan Loff Sabine Stegmaier Monika Sparber‐Sauer Felix Niggli Ruth Ladenstein Bernarda Kazanowska Gustaf Ljungman Kirsi Jahnukainen Jrg Fuchs Stefan S. Bielack Ewa Koscielniak Thomas Klingebiel 《Pediatric blood & cancer》2020,67(2)
45.
46.
《Journal of vascular and interventional radiology : JVIR》2020,31(1):25-34
PurposeTo investigate the safety of yttrium-90 radioembolization in combination with checkpoint inhibitor immunotherapy for the treatment of hepatocellular carcinoma (HCC).Materials and MethodsThis single-center retrospective study included 26 consecutive patients with HCC who received checkpoint inhibitor immunotherapy within 90 days of radioembolization from April 2015 to May 2018. Patients had preserved liver function (Child-Pugh scores A–B7) and either advanced HCC due to macrovascular invasion or limited extrahepatic disease (21 patients) or aggressive intermediate stage HCC that resulted in earlier incorporation of systemic immunotherapy (5 patients). Clinical documentation, laboratory results, and imaging results at 1- and 3-month follow-up intervals were reviewed to assess treatment-related adverse events and treatment responses.ResultsThe median follow-up period after radioembolization was 7.8 months (95% confidence interval [CI], 5.6–11.8). There were no early (30-day) mortality or grades 3/4 hepatobiliary or immunotherapy-related toxicities. Delayed grades 3/4 hepatobiliary toxicities (1–3 months) occurred in 2 patients in the setting of HCC disease progression. One patient developed pneumonitis. The median overall survival from first immunotherapy was 17.2 months (95% CI, 10.9–23.4). The median overall survival from first radioembolization was 16.5 months (95% CI, 6.6–26.4). From first radioembolization, time to tumor progression was 5.7 months (95% CI, 4.2–7.2), and progression-free survival was 5.7 months (95% CI, 4.3–7.1).ConclusionsRadioembolization combined with checkpoint inhibitor immunotherapy in cases of HCC appears to be safe and causes limited treatment-related toxicity. Future prospective studies are needed to identify the optimal combination treatment protocols and evaluate the efficacy of combination therapy. 相似文献
47.
48.
Daisuke Ishibashi Takeshi Ishikawa Satoshi Mizuta Hiroya Tange Takehiro Nakagaki Tsuyoshi Hamada Noriyuki Nishida 《Neurotherapeutics》2020,17(4):1836
The accumulation of abnormal prion protein (PrPSc) produced by the structure conversion of PrP (PrPC) in the brain induces prion disease. Although the conversion process of the protein is still not fully elucidated, it has been known that the intramolecular chemical bridging in the most fragile pocket of PrP, known as the “hot spot,” stabilizes the structure of PrPC and inhibits the conversion process. Using our original structure-based drug discovery algorithm, we identified the low molecular weight compounds that predicted binding to the hot spot. NPR-130 and NPR-162 strongly bound to recombinant PrP in vitro, and fragment molecular orbital (FMO) analysis indicated that the high affinity of those candidates to the PrP is largely dependent on nonpolar interactions, such as van der Waals interactions. Those NPRs showed not only significant reduction of the PrPSc levels but also remarkable decrease of the number of aggresomes in persistently prion-infected cells. Intriguingly, treatment with those candidate compounds significantly prolonged the survival period of prion-infected mice and suppressed prion disease-specific pathological damage, such as vacuole degeneration, PrPSc accumulation, microgliosis, and astrogliosis in the brain, suggesting their possible clinical use. Our results indicate that in silico drug discovery using NUDE/DEGIMA may be widely useful to identify candidate compounds that effectively stabilize the protein.Electronic supplementary materialThe online version of this article (10.1007/s13311-020-00903-9) contains supplementary material, which is available to authorized users. 相似文献
49.
50.